Who We Help

Who We Help

We partner with organizations across healthcare, life sciences, and technology—including biopharma companies, hospital systems, AI companies, and investors.


Our mission is to ensure that the right medicine reaches the right patient at the right time—affordably, effectively, and equitably.

Life Sciences & Biopharma Companies

We support life sciences and biopharma companies across the entire product lifecycle—from early research and development to medical affairs and commercialization.


Our team helps answer high-stakes questions using real-world data, advanced AI models, and outcomes research approaches, such as:

  • Which patient populations should we prioritize?
  • What evidence is needed to support market access?
  • How can we demonstrate value beyond clinical trials?

Whether you're designing a study, validating a strategy, or preparing for launch, we deliver clear, credible insights at every stage.

Life Sciences & Biopharma Companies

AI & Technology Companies

We partner with AI, software, and data companies building solutions for healthcare and life sciences.


Our support includes:

  • Helping you understand how health systems and biopharma teams make decisions
  • Identifying the right stakeholders and decision-makers
  • Shaping your messaging and offerings to align with clinical, regulatory, and commercial needs

If you're a tech team building for this space, we help ensure your strategy resonates—and your story lands in the right rooms.

AI & Technology Companies

Clinics & Health Systems

We help hospital networks, academic medical centers, and independent clinics unlock more value from the data they already have. Our support includes:

  • Cleaning and organizing real-world data sources
  • Identifying opportunities to apply AI and natural language processing (NLP)
  • Building solutions that integrate seamlessly into clinical workflows

We go beyond advice—we work alongside your team to test, measure, and implement solutions that drive real improvements in care and operations.

Clinics & Health Systems

Investment Firms & VCs

We support healthcare-focused investors with strategic, evidence-based insights, including:

  • Independent market assessments
  • Due diligence on emerging technologies
  • Competitive landscape and trend analysis
  • Evaluation of data science and real-world evidence (RWE) capabilities in target organizations

Our goal is to equip you with clear, structured intelligence—not just slide decks—so you can make confident, well-informed investment decisions.

Investment Firms & VCs
Request a consultation

Case Studies

Real-World Database Study: Women's Health in the Asia Pacific Market Expansion
Real-World Database Study: Women's Health in the Asia Pacific Market Expansion
Read more
AI-Powered Infectious Disease Surveillance for a Global Vaccine Manufacturer
AI-Powered Infectious Disease Surveillance for a Global Vaccine Manufacturer
Read more
Systematic Literature Review of Factor Xa Inhibitors in Real-World Clinical Settings
Systematic Literature Review of Factor Xa Inhibitors in Real-World Clinical Settings
Read more
Multimodal Analysis of Genomics, Imaging & Clinical Data (MAGIC)
Multimodal Analysis of Genomics, Imaging & Clinical Data (MAGIC)
Read more

Our Latest Thinking on Healthcare

Patient_Reported_With_Doctor
Patient-Reported Outcomes: Bringing the Patient’s Voice into Clinical Development and Outcomes Research
Aug 14, 2025
When it comes to healthcare, numbers and lab results only tell part of the story. What about how patients feel? How treatments impact their daily lives?...
Read more
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Powerful AI Starts with High-Quality Data: Lessons from Edwin Chen and Surge AI
Jul 28, 2025
In a world where AI headlines are dominated by billion-dollar fundraises, massive model sizes, and compute power arms races, Edwin Chen offers a refreshing counter-narrative. As...
Read more
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Understanding Health Technology Assessment (HTA): A Strategic Imperative for Innovators
Jul 15, 2025
If you're a scientist transitioning into the biotechnology sector or an entrepreneur developing a novel therapy for an unmet medical need, one term will...
Read more
View all